JNJ
JOHNSON & JOHNSON- Sector
- Health Care
- Industry
- Pharmaceuticals
- Last price
- $240.87
- As of
Active signals for JNJ
- highTRIAL_TERMINATION
Phase 3 trial terminated early — JOHNSON An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the
- highTRIAL_TERMINATION
Phase 3 trial terminated early — JOHNSON A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Dise
- highTRIAL_TERMINATION
Phase 3 trial terminated early — JOHNSON To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Canc
- highTRIAL_TERMINATION
Phase 3 trial terminated early — JOHNSON A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hyd
- highTRIAL_TERMINATION
Phase 3 trial terminated early — JOHNSON A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus P
Recent SEC filings, JNJ
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
Related tickers in Health Care
See more JNJ signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track JNJ in your watchlist and get notified the moment a new signal fires.
Track JNJ on Kresmion →